Chong Kun Dang Pharmaceutical (185750) — Cash Flow Reinvestment Rate
Chong Kun Dang Pharmaceutical (185750) has a Cash Flow Reinvestment Rate of 7.99x as of September 2025, reinvesting ₩171.35 Billion (capex ₩104.14 Billion plus investments ₩67.21 Billion) from operating cash flow of ₩21.45 Billion. Explore 185750 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chong Kun Dang Pharmaceutical Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Chong Kun Dang Pharmaceutical across 9 annual periods. Also explore balance sheet size of Chong Kun Dang Pharmaceutical for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Chong Kun Dang Pharmaceutical (2016–2024)
Year-by-year capital reinvestment analysis for Chong Kun Dang Pharmaceutical. For live market cap and broader valuation context, see Chong Kun Dang Pharmaceutical market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.11x | ₩135.37 Billion | ₩64.29 Billion | ₩66.10 Billion | ▲ +179.0% |
| 2023 | 0.75x | ₩240.12 Billion | ₩318.16 Billion | ₩68.81 Billion | ▼ -11.4% |
| 2022 | 0.85x | ₩57.70 Billion | ₩67.73 Billion | ₩44.90 Billion | ▼ -87.4% |
| 2021 | 6.79x | ₩87.57 Billion | ₩12.90 Billion | ₩48.24 Billion | ▲ +1078.5% |
| 2020 | 0.58x | ₩60.08 Billion | ₩104.32 Billion | ₩32.64 Billion | ▲ +20.0% |
| 2019 | 0.48x | ₩37.09 Billion | ₩77.29 Billion | ₩21.84 Billion | ▼ -27.3% |
| 2018 | 0.66x | ₩28.12 Billion | ₩42.63 Billion | ₩21.92 Billion | ▲ +134.3% |
| 2017 | 0.28x | ₩23.00 Billion | ₩81.67 Billion | ₩19.79 Billion | ▼ -80.4% |
| 2016 | 1.43x | ₩82.84 Billion | ₩57.79 Billion | ₩39.44 Billion | — |